HEADER DNA/ANTIBIOTIC 08-MAR-22 7X6R TITLE CRYSTAL STRUCTURE OF ACTINOMYCIN D-ECHINOMYCIN-D(AGCACGT/ACGGGCT) TITLE 2 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: DNA (5'-D(P*AP*GP*CP*AP*CP*GP*T)-3'); COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: DNA (5'-D(P*AP*CP*GP*GP*GP*CP*T)-3'); COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: ACTINOMYCIN D; COMPND 11 CHAIN: C; COMPND 12 MOL_ID: 4; COMPND 13 MOLECULE: DSN-ALA-N2C-MVA-DSN-ALA-NCY-MVA; COMPND 14 CHAIN: D SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 4 ORGANISM_TAXID: 32630; SOURCE 5 MOL_ID: 2; SOURCE 6 SYNTHETIC: YES; SOURCE 7 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 8 ORGANISM_TAXID: 32630; SOURCE 9 MOL_ID: 3; SOURCE 10 ORGANISM_SCIENTIFIC: STREPTOMYCES; SOURCE 11 ORGANISM_TAXID: 1883; SOURCE 12 MOL_ID: 4; SOURCE 13 ORGANISM_SCIENTIFIC: STREPTOMYCES; SOURCE 14 ORGANISM_TAXID: 1883 KEYWDS A:G MISMATCH, SINGLE-STRAND DNA DISTORTION, ACTINOMYCIN D, KEYWDS 2 ECHINOMYCIN, MISMATCH BINDING DRUG, DNA, DNA-ANTIBIOTIC COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.H.KAO,R.B.SATANGE,M.H.HOU REVDAT 3 29-NOV-23 7X6R 1 REMARK REVDAT 2 15-NOV-23 7X6R 1 LINK ATOM REVDAT 1 14-DEC-22 7X6R 0 JRNL AUTH R.SATANGE,S.H.KAO,C.M.CHIEN,S.H.CHOU,C.C.LIN,S.NEIDLE, JRNL AUTH 2 M.H.HOU JRNL TITL STAGGERED INTERCALATION OF DNA DUPLEXES WITH BASE-PAIR JRNL TITL 2 MODULATION BY TWO DISTINCT DRUG MOLECULES INDUCES ASYMMETRIC JRNL TITL 3 BACKBONE TWISTING AND STRUCTURE POLYMORPHISM. JRNL REF NUCLEIC ACIDS RES. V. 50 8867 2022 JRNL REFN ESSN 1362-4962 JRNL PMID 35871296 JRNL DOI 10.1093/NAR/GKAC629 REMARK 2 REMARK 2 RESOLUTION. 1.89 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14_3260 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.89 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.72 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 5355 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.246 REMARK 3 R VALUE (WORKING SET) : 0.244 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.050 REMARK 3 FREE R VALUE TEST SET COUNT : 538 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 27.7230 - 2.9986 0.96 1266 141 0.2071 0.2127 REMARK 3 2 2.9986 - 2.3805 1.00 1207 134 0.3079 0.3452 REMARK 3 3 2.3805 - 2.0797 0.99 1175 132 0.2911 0.3092 REMARK 3 4 2.0797 - 1.8900 0.99 1169 131 0.3222 0.4115 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.260 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 35.220 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.31 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 59.4546 51.6124 82.6273 REMARK 3 T TENSOR REMARK 3 T11: 0.3386 T22: 0.3165 REMARK 3 T33: 0.2809 T12: 0.0183 REMARK 3 T13: 0.0656 T23: 0.0200 REMARK 3 L TENSOR REMARK 3 L11: 4.9355 L22: 6.5919 REMARK 3 L33: 6.3142 L12: -2.5913 REMARK 3 L13: -2.0109 L23: 4.9146 REMARK 3 S TENSOR REMARK 3 S11: 0.0381 S12: 0.0173 S13: 0.1909 REMARK 3 S21: 0.2490 S22: -0.0314 S23: 0.0977 REMARK 3 S31: -0.0511 S32: -0.6867 S33: -0.0308 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7X6R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-MAR-22. REMARK 100 THE DEPOSITION ID IS D_1300028165. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-JAN-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSRRC REMARK 200 BEAMLINE : BL15A1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 5402 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.890 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 13.30 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : 0.04000 REMARK 200 FOR THE DATA SET : 43.1120 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.89 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.92 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.34300 REMARK 200 R SYM FOR SHELL (I) : 0.34300 REMARK 200 FOR SHELL : 10.11 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX 1.14_3260 REMARK 200 STARTING MODEL: 7DQ0 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.37 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.25 MM OLIGONUCLEOTIDE, 0.25 MM REMARK 280 ECHINOMYCIN, 0.125 MM ACTINOMYCIN D, 2.5 MM SODIUM CACODYLATE REMARK 280 (PH 6.5), 2.5 MM MAGNESIUM CHLORIDE, 2 MM SPERMINE REMARK 280 TETRAHYDROCHLORIDE, 6 MM COBALT CHLORIDE, 2% V/V PEG 200, 4% V/V REMARK 280 MPD, RESERVOIR PEG 200 (30%), VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 4 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y,X,Z REMARK 290 4555 Y,-X,Z REMARK 290 5555 -X,Y,-Z REMARK 290 6555 X,-Y,-Z REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 CO CO A 101 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 203 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 207 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 209 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 206 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 208 LIES ON A SPECIAL POSITION. REMARK 375 HOH C 101 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 ACTINOMYCIN D IS A BICYCLIC PEPTIDE, A MEMBER OF THE REMARK 400 ACTINOMYCIN FAMILY. REMARK 400 HERE, ACTINOMYCIN D IS REPRESENTED BY THE SEQUENCE (SEQRES) REMARK 400 THE ECHINOMYCIN IS A BICYCLIC OCTADEPSIPEPTIDE, A MEMBER REMARK 400 OF THE QUINOXALINE CLASS OF ANTIBIOTICS. REMARK 400 HERE, ECHINOMYCIN IS REPRESENTED BY GROUPING TOGETHER THE REMARK 400 SEQUENCE (SEQRES) AND TWO LIGANDS (HET) QUI. REMARK 400 REMARK 400 THE ACTINOMYCIN D IS POLYPEPTIDE, A MEMBER OF ANTIBIOTIC CLASS. REMARK 400 REMARK 400 THE ECHINOMYCIN IS CYCLIC DEPSIPEPTIDE, A MEMBER OF ANTIBIOTIC REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: ACTINOMYCIN D REMARK 400 CHAIN: C REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: ACTINOMYCIN D CONSISTS OF TWO PENTAMER RINGS LINKED REMARK 400 BY THE CHROMOPHORE (PXZ) REMARK 400 REMARK 400 GROUP: 2 REMARK 400 NAME: ECHINOMYCIN REMARK 400 CHAIN: D REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 COMPONENT_2: RESIDUE QUI REMARK 400 DESCRIPTION: ECHINOMYCIN IS A BICYCLIC OCTADEPSIPEPTIDE. REMARK 400 BICYCLIZATION IS ACHIEVED BY LINKING THE N- AND THE REMARK 400 C- TERMINI, AND A THIOACETAL BOND BETWEEN RESIDUES 3 REMARK 400 AND 7. THE TWO QUINOXALINE CHROMOPHORES ARE LINKED REMARK 400 TO THE D-SERINE RESIDUES, RESIDUES 1 AND 5. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CO CO B 101 O HOH B 204 1.68 REMARK 500 OG1 THR C 1 O MVA C 5 2.14 REMARK 500 OG1 THR C 1 CA MVA C 5 2.14 REMARK 500 OG DSN D 1 O MVA D 8 2.15 REMARK 500 OG1 THR C 7 CA MVA C 11 2.16 REMARK 500 CB THR C 7 C MVA C 11 2.16 REMARK 500 O HOH B 202 O HOH B 204 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH C 102 DISTANCE = 6.19 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CO A 101 CO REMARK 620 N RES CSSEQI ATOM REMARK 620 1 DG A 6 N7 REMARK 620 2 DG A 6 N7 0.0 REMARK 620 3 HOH A 201 O 95.0 95.0 REMARK 620 4 HOH A 201 O 87.4 87.4 97.6 REMARK 620 5 HOH D 201 O 87.4 87.4 88.1 172.6 REMARK 620 6 HOH D 201 O 89.9 89.9 172.6 88.1 86.6 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CO B 101 CO REMARK 620 N RES CSSEQI ATOM REMARK 620 1 DG B 4 N7 REMARK 620 2 HOH B 201 O 107.6 REMARK 620 3 HOH B 202 O 92.2 97.8 REMARK 620 4 HOH B 205 O 98.7 95.5 159.4 REMARK 620 5 HOH B 207 O 172.8 73.9 94.6 74.1 REMARK 620 N 1 2 3 4 DBREF 7X6R A 1 7 PDB 7X6R 7X6R 1 7 DBREF 7X6R B 1 7 PDB 7X6R 7X6R 1 7 DBREF 7X6R C 1 11 PDB 7X6R 7X6R 1 11 DBREF 7X6R D 1 8 PDB 7X6R 7X6R 1 8 SEQRES 1 A 7 DA DG DC DA DC DG DT SEQRES 1 B 7 DA DC DG DG DG DC DT SEQRES 1 C 11 THR DVA PRO SAR MVA PXZ THR DVA PRO SAR MVA SEQRES 1 D 8 DSN ALA N2C MVA DSN ALA NCY MVA HET DVA C 2 7 HET SAR C 4 5 HET MVA C 5 8 HET PXZ C 6 22 HET DVA C 8 7 HET SAR C 10 5 HET MVA C 11 8 HET DSN D 1 6 HET N2C D 3 8 HET MVA D 4 8 HET DSN D 5 6 HET NCY D 7 7 HET MVA D 8 8 HET CO A 101 1 HET CO B 101 1 HET CO B 102 1 HET QUI D 101 12 HET QUI D 102 12 HETNAM DVA D-VALINE HETNAM SAR SARCOSINE HETNAM MVA N-METHYLVALINE HETNAM PXZ 2-AMINO-1,9-DICARBONYL-4,6-DIMETHYL-10-DEHYDRO- HETNAM 2 PXZ PHENOXAZIN-3-ONE HETNAM DSN D-SERINE HETNAM N2C N,S-DIMETHYLCYSTEINE HETNAM NCY N-METHYLCYSTEINE HETNAM CO COBALT (II) ION HETNAM QUI 2-CARBOXYQUINOXALINE HETSYN PXZ PHENOXAZINE FORMUL 3 DVA 2(C5 H11 N O2) FORMUL 3 SAR 2(C3 H7 N O2) FORMUL 3 MVA 4(C6 H13 N O2) FORMUL 3 PXZ C16 H12 N2 O4 FORMUL 4 DSN 2(C3 H7 N O3) FORMUL 4 N2C C5 H11 N O2 S FORMUL 4 NCY C4 H9 N O2 S FORMUL 5 CO 3(CO 2+) FORMUL 8 QUI 2(C9 H6 N2 O2) FORMUL 10 HOH *23(H2 O) SSBOND 1 N2C D 3 NCY D 7 1555 1555 2.85 LINK C THR C 1 N DVA C 2 1555 1555 1.33 LINK OG1 THR C 1 C MVA C 5 1555 1555 1.38 LINK N THR C 1 C0 PXZ C 6 1555 1555 1.43 LINK C DVA C 2 N PRO C 3 1555 1555 1.34 LINK C PRO C 3 N SAR C 4 1555 1555 1.33 LINK C SAR C 4 N MVA C 5 1555 1555 1.33 LINK C0' PXZ C 6 N THR C 7 1555 1555 1.43 LINK C THR C 7 N DVA C 8 1555 1555 1.33 LINK OG1 THR C 7 C MVA C 11 1555 1555 1.39 LINK C DVA C 8 N PRO C 9 1555 1555 1.35 LINK C PRO C 9 N SAR C 10 1555 1555 1.33 LINK C SAR C 10 N MVA C 11 1555 1555 1.33 LINK C DSN D 1 N ALA D 2 1555 1555 1.33 LINK OG DSN D 1 C MVA D 8 1555 1555 1.38 LINK N DSN D 1 C QUI D 102 1555 1555 1.43 LINK C ALA D 2 N N2C D 3 1555 1555 1.34 LINK C N2C D 3 N MVA D 4 1555 1555 1.32 LINK CB N2C D 3 SG NCY D 7 1555 1555 1.77 LINK C MVA D 4 OG DSN D 5 1555 1555 1.37 LINK C DSN D 5 N ALA D 6 1555 1555 1.33 LINK N DSN D 5 C QUI D 101 1555 1555 1.43 LINK C ALA D 6 N NCY D 7 1555 1555 1.33 LINK C NCY D 7 N MVA D 8 1555 1555 1.33 LINK N7 DG A 6 CO CO A 101 1555 1555 2.13 LINK N7 DG A 6 CO CO A 101 1555 2875 2.13 LINK CO CO A 101 O HOH A 201 1555 1555 2.05 LINK CO CO A 101 O HOH A 201 1555 2875 2.05 LINK CO CO A 101 O HOH D 201 1555 1555 2.10 LINK CO CO A 101 O HOH D 201 1555 2875 2.10 LINK N7 DG B 3 CO CO B 102 1555 1555 2.12 LINK N7 DG B 4 CO CO B 101 1555 1555 2.06 LINK CO CO B 101 O HOH B 201 1555 1555 1.94 LINK CO CO B 101 O HOH B 202 1555 1555 1.70 LINK CO CO B 101 O HOH B 205 1555 1555 2.00 LINK CO CO B 101 O HOH B 207 1555 1555 2.04 CISPEP 1 DVA C 2 PRO C 3 0 9.13 CISPEP 2 PRO C 3 SAR C 4 0 -8.58 CISPEP 3 DVA C 8 PRO C 9 0 9.07 CISPEP 4 PRO C 9 SAR C 10 0 -6.22 CRYST1 43.225 43.225 65.839 90.00 90.00 90.00 P 4 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023135 0.000000 0.000000 0.00000 SCALE2 0.000000 0.023135 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015189 0.00000